Health Care & Life Sciences » Pharmaceuticals | Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
59,236
65,216
75,617
90,794
91,031
Cost of Goods Sold (COGS) incl. D&A
29,224
32,427
41,564
47,450
52,645
Gross Income
30,012
32,788
34,053
43,344
38,386
SG&A Expense
19,214
23,945
22,361
28,743
25,776
EBIT
10,798
8,844
-
14,602
12,610
Unusual Expense
2,175
-
56
-
-
Non Operating Income/Expense
166
1,014
124
192
914
Interest Expense
1,886
1,902
1,789
2,373
2,856
Pretax Income
6,969
5,943
10,047
12,602
10,668
Income Tax
1,513
1,190
3,028
3,442
2,925
Consolidated Net Income
5,456
4,752
7,019
9,159
7,743
Net Income
5,423
4,753
7,021
9,160
7,743
Net Income After Extraordinaries
5,423
4,753
7,021
9,160
7,743
Net Income Available to Common
5,423
4,753
7,021
9,160
7,743
EPS (Basic)
20.01
17.52
25.01
32.46
27.44
Basic Shares Outstanding
271
271
281
282
-
EPS (Diluted)
20.00
17.52
25.00
32.45
-
Diluted Shares Outstanding
271
271
281
282
-
EBITDA
12,966
11,444
14,328
20,367
16,150
Non-Operating Interest Income
66
14
76
181
-
Minority Interest Expense
33
1
2
-
-

About Glenmark Pharmaceuticals

View Profile
Address
Glenmark House, HDO Corporate Bldg
Mumbai Maharashtra 400099
India
Employees -
Website http://www.glenmarkpharma.com
Updated 09/14/2018
Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.